Back
Agfa-Gevaert NV 10K Form
Sell
16
AFGVY
Agfa-Gevaert NV
Last Price:
2.60
Seasonality Move:
-6.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AFGVY News And Ratings
See the #1 stock for the next 7 days that we like better than AFGVY
AFGVY Financial Statistics
Sales & Book Value
| Annual Sales: | $1.25B |
|---|---|
| Cash Flow: | $-43.82M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.26 |
| Price / Book: | 0.49 |
Profitability
| EPS (TTM): | -0.52190 |
|---|---|
| Net Income (TTM): | $-39.14M |
| Gross Margin: | $387.57M |
| Return on Equity: | -8.97% |
| Return on Assets: | -2.62% |
Agfa-Gevaert NV Earnings Forecast
Key Agfa-Gevaert NV Financial Ratios
- The Gross Profit Margin over the past 22 years for AFGVY is 31.13%.
- The Selling, General & Administrative Expenses for AFGVY have been equal to 26.96% of Gross Profit Margin.
- The Research & Development expenses have been 6.35% of Revenue.
- The Interest Expense is -37.25% of Operating Income.
- The Net Earning history of AFGVY is -8.87% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 13 years.
Agfa-Gevaert NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | AFGVY |
| Website: | agfa.com |
Debt
| Debt-to-Equity Ratio: | 0.44 |
|---|---|
| Current Ratio: | 2.14 |
| Quick Ratio: | 1.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AFGVY Technical Analysis vs Fundamental Analysis
Sell
16
Agfa-Gevaert NV (AFGVY)
is a Sell
Is Agfa-Gevaert NV a Buy or a Sell?
-
Agfa-Gevaert NV stock is rated a Sell
The current Agfa-Gevaert NV [AFGVY] share price is $2.60. The Score for AFGVY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.